Effect of interferon therapy on bile duct inflammation in hepatitis C

Virchows Archiv

Volumn 428, Issue 4-5, 1996, Pages 253-259

  Banner, Barbara F ^a   Allan, Carol ^a   Smith, Lynda ^a   Savas, Louis ^a   Bonkovsky, Herbert L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bile duct inflammation; Hepatitis C

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA2B INTERFERON; BETA 2 MICROGLOBULIN; HLA DR ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT; CLINICAL ARTICLE; DIGESTIVE SYSTEM INFLAMMATION; FEMALE; FROZEN SECTION; HEPATITIS C; HUMAN; LIVER BIOPSY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL;

EID: 0029811608     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00196698     Document Type: Article

References (22)

1. Bach N, Thung SN, Schaffner F (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis. A comparative analysis. Hepatology 15:572-577
2. Christoffersen P, Dietrichson O, Faber V, Poulsen H (1972) The occurrence and significance of abnormal bile duct epithelium in chronic aggressive hepatitis. Acta Pathol Microbiol Scand [A] 80:294-302
3. Czaja AJ, Carpenter HA (1993) Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 105:1824-1832
4. Danque POV, Bach N, Schaffner F, Gerber MA, Thung SN (1993) HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol 6:327-332
5. David E, Pucci A, Palladin D, Saracco G, Garello E, Pintus C, Rocca G, Chiandussi L, Solinas A, Mollo F, Rizzetto M, Mazzucco G, Verme G (1992) Histologic changes in liver biopsy specimens produced by recombinant Interferon alpha-2b therapy for chronic Non-A, Non-B viral hepatitis. Am J Clin Pathol 98:397-401
6. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A (1989) Treatment of chronic hepatitis C with recombinant interferon alpha. A mulicenter randomized, controlled trial. N Engl J Med 321:1501-1506
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading, and staging. Hepatology 19:1513-1520
8. DiBisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks S, Hoffnagle JH (1989) Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510
9. Finkelstein SD, Sayegh R, Uchman S, Christensen S, Swalsky PA, Bodenheimer H (1994) Disease activity of hepatitis C correlates with single-strand polymerase chain reaction detection of hepatitis C virus. Am J Clin Pathol 101:321-326
10. Gerber MA (1995) Pathobiologic effects of hepatitis C. J Hepatol 22 [Suppl 1]:83-86
11. Ishak KG (1994) Chronic hepatitis: morphology and nomenclature. Mod Phatol 7:690-713
12. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobajushi K, Nonomura A, Tsuneyama K, Van de Water J, Gershwin ME (1994) Hepatic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Mod Pathol 7:937-945
13. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan T, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435
14. Lefkowitch JH, Schiff ER, Davis GL, Perrillo P, Lindsay K, Bodenheimer HC Jr, Balart LA, Ortego TJ, Payne J, Dienstag JL, Gibas A, Jacobson IM, Tamburro CH, Carey W, O'Brien C, Sampliner R, VanThiel DH, Geit D, Albrecht J, Meschievitz C, Sanghvi B, Vaughan RD (1993) Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 104:595-603
15. Omata M, Ito Y, Yokosuka O, Imazeki F, Uchiumi K, Takano S, Hododa K, Ohta M (1989) Histological changes of the liver by treatment of chronic Non-A, Non-B hepatitis with recombinant leukocyte Interferon Alpha. Comparison with histological changes in chronic hepatitis B. Dig Dis Sci 34:330-337
16. Poulsen H, Christoffersen P (1969) Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Pathol Microbiol Scand 76:383-390
17. Poulsen H, Christoffersen P (1972) Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis. A review of morphology and clinical, biochemical, and immunologic features. Hum Pathol 3:217-225
18. Schvarcz R, Glaumann H, Weiland O, Norkrans G, Sejstal R, Fryden A (1991) Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis. Liver 11:30-38
19. Van den Oord JJ, Sciot R, Desmet VJ (1986) Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol 3:310-317
20. Van Thiel DH, Zhang X, Baddour N, Wright HI, Friedlander L, Gavaler JS (1994) Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis B: effect of interferon-a. Dig Dis Sci 39:970-9715
21. Villari D, Raimondo G, Freni MA, Rodino GI, Aiello A, Fava A, Longo GI, Batolo D (1992) Histological behaviour of chronic hepatitis in patients treated with alpha interferon. Pathology 24:243-246
22. Vyberg M (1993) The hepatitis-associated bile duct lesion. Liver 13:289-301